Status:
COMPLETED
A Comparison of Collagen, Lidocaine and Saline, in Trigger Points in Masseter Muscle.
Lead Sponsor:
Medical University of Silesia
Conditions:
Temporomandibular Disorder
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
An intramusclular injection of three solutions were performed( collagen, lidocaine, saline) in musculoskeletal trigger points, in patients suffering from temporomandibular disorders(TMD). Best results...
Detailed Description
Collagen is an important component, building myocytes and extracellular matrix of skeletal muscles. The novel treatment option for trigger point therapy and muscle regeneration in TMD patients are int...
Eligibility Criteria
Inclusion
- \- sleep bruxism, DC/TMD myofascial pain, myofascial pain with referral
Exclusion
- younger than 18years old, active orthodonctic treatment,neurological treatment, post radiotherapy, after head trauma within 2 years, patients with unsupported occlusal contacts, addicted to analgesic drugs, with the fear of needle
Key Trial Info
Start Date :
January 10 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2017
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03323567
Start Date
January 10 2016
End Date
October 12 2017
Last Update
January 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of TMD and Orthodontics Silesian Medical University
Zabrze, Poland, 41-800